| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T163 |
20-36 |
CHEBI:35705;CHEBI:35705 |
denotes |
immunomodulatory |
| T69247 |
35-50 |
CHEBI:35705;CHEBI:35705 |
denotes |
y drugs such as |
| T164 |
37-42 |
CHEBI:23888;CHEBI:23888 |
denotes |
drugs |
| T20303 |
51-56 |
CHEBI:23888;CHEBI:23888 |
denotes |
anaki |
| T165 |
73-88 |
PR:000001137 |
denotes |
interleukin-1Ra |
| T81754 |
87-93 |
PR:000001137 |
denotes |
a), to |
| T166 |
91-102 |
DG_35 |
denotes |
tocilizumab |
| T16643 |
96-107 |
DG_35 |
denotes |
izumab (ant |
| T167 |
109-122 |
PR:000001393 |
denotes |
interleukin-6 |
| T55627 |
114-117 |
PR:000001393 |
denotes |
leu |
| T168 |
141-151 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitors |
| T41646 |
142-152 |
CHEBI:35222;CHEBI:35222 |
denotes |
nhibitors, |
| T169 |
185-193 |
SP_7 |
denotes |
COVID-19 |
| T67111 |
186-193 |
SP_7 |
denotes |
OVID-19 |
| T170 |
495-504 |
UBERON:0002048 |
denotes |
pulmonary |
| T31029 |
495-504 |
UBERON:0002048 |
denotes |
pulmonary |
| T56928 |
623-630 |
SP_7 |
denotes |
COVID-1 |
| T171 |
623-631 |
SP_7 |
denotes |
COVID-19 |
| T40668 |
631-640 |
UBERON:0002048 |
denotes |
pulmonar |
| T172 |
632-641 |
UBERON:0002048 |
denotes |
pulmonary |
| T57506 |
723-734 |
UBERON:0001004 |
denotes |
respirator |
| T173 |
724-735 |
UBERON:0001004 |
denotes |
respiratory |
| T68575 |
768-776 |
SP_7 |
denotes |
COVID-1 |
| T174 |
769-777 |
SP_7 |
denotes |
COVID-19 |
